Human Pathology
Volume 37, Issue 3 , Pages 283-291 , March 2006

Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma

  • Shinichi Aishima, MD

      Affiliations

    • Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
    • Corresponding Author InformationCorresponding authors. Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
    • ,
  • Yousuke Kuroda

      Affiliations

    • Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
    • ,
  • Yoshiki Asayama, MD

      Affiliations

    • Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
    • ,
  • Kenichi Taguchi, MD

      Affiliations

    • Institute for Clinical Research, National Kyushu Cancer Center, Fukuoka 811-1395, Japan
    • ,
  • Yunosuke Nishihara

      Affiliations

    • Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
    • ,
  • Akinobu Taketomi, MD

      Affiliations

    • Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
    • ,
  • Masazumi Tsuneyoshi, MD

      Affiliations

    • Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
    • Corresponding Author InformationCorresponding authors. Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

Received 27 January 2005 ,Accepted 3 August 2005.

References 

  1. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol. 1949;25:647–655
  2. Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer. 1985;55:124–135
  3. Maeda T, Adachi E, Kajiyama K, et al. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. Hum Pathol. 1995;26:956–964
  4. Nakamura S, Suzuki S, Sakaguchi T, et al. Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma. Cancer. 1996;78:1671–1676
  5. Taguchi J, Nakashima O, Tanaka M, et al. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol. 1996;11:758–764
  6. Robrechts C, De Vos R, Van den Heuvel M, et al. Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour?. Liver. 1998;18:288–293
  7. Tickoo SK, Zee SY, Obiekwe S, et al. Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. Am J Surg Pathol. 2002;26:989–997
  8. Kim H, Park C, Han KH, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol. 2004;40:298–304
  9. Ng IO, Shek TW, Nicholls J, et al. Combined hepatocellular-cholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol. 1998;13:34–40
  10. Jarnagin WR, Weber S, Tickoo SK, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer. 2002;94:2040–2046
  11. Yano Y, Yamamoto J, Kosuge T, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol. 2003;33:283–287
  12. Nishi H, Taguchi K, Asayama Y, et al. Sarcomatous hepatocellular carcinoma: a special reference to ordinary hepatocellular carcinoma. J Gastroenterol Hepatol. 2003;18:415–423
  13. Shimada M, Takenaka K, Rikimaru T, et al. Characteristics of sarcomatous cholangiocarcinoma of the liver. Hepatogastroenterology. 2000;47:956–961
  14. Ishak KG, Anthony PP, Sobin LH. Histologic typing of tumors of the liver. World Health Organization: international histologic classification of tumors. 2nd ed.. Berlin: Springer-Verlag; 1994;
  15. Wittekind C, Fischer HP, Ponchon T. Combined hepatocellular and cholangiocarcinoma. In: World Health Organization classification of tumours: pathology and genetics of tumours of the digestive system. Lyon (France): IARC Press; 2000;p. 181
  16. Itoh S, Maeda T, Shimada M, et al. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res. 2004;10:2812–2817
  17. Aishima S, Taguchi K, Terashi T, et al. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma. Mod Pathol. 2003;16:1019–1027
  18. Fan Z, van de Rijn M, Montgomery K, et al. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol. 2003;16:137–144
  19. Chu PG, Ishizawa S, Wu E, et al. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol. 2002;26:978–988
  20. Haratake J, Horie A. An immunohistochemical study of sarcomatoid liver carcinomas. Cancer. 1991;68:93–97
  21. Murata M, Miyoshi Y, Iwao K, et al. Combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features: genetic analysis for histogenesis. Hepatol Res. 2001;21:220–227
  22. Nakajima T, Kubosawa H, Kondo Y, et al. Combined hepatocellular-cholangiocarcinoma with variable sarcomatous transformation. Am J Clin Pathol. 1988;90:309–312
  23. Papotti M, Sambataro D, Marchesa P, et al. A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features. Liver. 1997;17:47–52

☆ This study was supported in part by a Grant-in-Aid for Scientific Research (15790187) from the Japan Society of the Promotion of Science, Tokyo, Japan.

PII: S0046-8177(05)00472-7

doi: 10.1016/j.humpath.2005.08.019

Human Pathology
Volume 37, Issue 3 , Pages 283-291 , March 2006

Article Tools

* Image Usage & Resolution